Corient Private Wealth’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$521K Sell
5,595
-5,824
-51% -$516K ﹤0.01% 2008
2025
Q4
$919K Buy
11,419
+5,849
+105% +$490K ﹤0.01% 1927
2025
Q3
$544K Buy
+5,570
New +$449K ﹤0.01% 1753
2024
Q4
Sell
-2,842
Closed -$298K 2359
2024
Q3
$298K Sell
2,842
-3,952
-58% -$462K ﹤0.01% 2015
2024
Q2
$966K Buy
6,794
+4,453
+190% +$513K ﹤0.01% 1346
2024
Q1
$261K Buy
2,341
+622
+36% +$74.1K ﹤0.01% 1968
2023
Q4
$223K Sell
1,719
-6
-0.3% -$827 ﹤0.01% 2013
2023
Q3
$281K Sell
1,725
-5
-0.3% -$879 ﹤0.01% 1777
2023
Q2
$317K Sell
1,730
-1,668
-49% -$240K ﹤0.01% 1672
2023
Q1
$453K Buy
+3,398
New +$399K ﹤0.01% 1426

Other funds holding ACLS

Corient Private Wealth's ACLS Position: Q1 2026 in Review

Corient Private Wealth reduced its Axcelis (ACLS) stake by 51% in Q1 2026, selling an estimated $516K and leaving 5,595 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

Corient Private Wealth first reported a position in ACLS in Q1 2023 and has held it in 10 quarters since. The position peaked at $966K in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Corient Private Wealth held 5,595 shares of Axcelis worth $521K as of Q1 2026.
  • Corient Private Wealth sold 5,824 Axcelis shares in Q1 2026, an estimated $516K.
  • Axcelis made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2008 holding.
  • Corient Private Wealth first reported a position in Axcelis in Q1 2023 and has held it in 10 quarters since.
  • Corient Private Wealth's Axcelis position peaked at $966K in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.